NCT00354744
Clinical Trial Information
Trial Number: NCT00354744 (ClinicalTrials.gov)
Disease Type:
- Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma
Study ID:
ARST0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00354744-D2 | NCT00354744-D2 This dataset contains incidence of adverse events as reported in the manuscript. |
| NCT00354744-D1 | NCT00354744-D1 There is one row for each patient enrolled. The dataset contains the patient characteristics, Oberlin risk groups, reporting period duration, radiation by reporting period, and survival outcomes for patients on ARST0431 as reported in the manuscript. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®